Literature DB >> 21080281

Targeting vector construction through recombineering.

Liviu A Malureanu1.   

Abstract

Gene targeting in mouse embryonic stem cells is an essential, yet still very expensive and highly time-consuming, tool and method to study gene function at the organismal level or to create mouse models of human diseases. Conventional cloning-based methods have been largely used for generating targeting vectors, but are hampered by a number of limiting factors, including the variety and location of restriction enzymes in the gene locus of interest, the specific PCR amplification of repetitive DNA sequences, and cloning of large DNA fragments. Recombineering is a technique that exploits the highly efficient homologous recombination function encoded by λ phage in Escherichia coli. Bacteriophage-based recombination can recombine homologous sequences as short as 30-50 bases, allowing manipulations such as insertion, deletion, or mutation of virtually any genomic region. The large availability of mouse genomic bacterial artificial chromosome (BAC) libraries covering most of the genome facilitates the retrieval of genomic DNA sequences from the bacterial chromosomes through recombineering. This chapter describes a successfully applied protocol and aims to be a detailed guide through the steps of generation of targeting vectors through recombineering.

Entities:  

Mesh:

Year:  2011        PMID: 21080281     DOI: 10.1007/978-1-60761-974-1_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  A protocol for construction of gene targeting vectors and generation of homologous recombinant embryonic stem cells.

Authors:  Hicham Bouabe; Klaus Okkenhaug
Journal:  Methods Mol Biol       Date:  2013

Review 2.  Homologous recombination in human embryonic stem cells: a tool for advancing cell therapy and understanding and treating human disease.

Authors:  Andrew D Leavitt; Isla Hamlett
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

3.  USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis.

Authors:  Ying Zhang; Oded Foreman; Dennis A Wigle; Farhad Kosari; George Vasmatzis; Jeffrey L Salisbury; Jan van Deursen; Paul J Galardy
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

4.  An asymmetric PCR-based, reliable and rapid single-tube native DNA engineering strategy.

Authors:  Yanzhen Bi; Xianfeng Qiao; Zaidong Hua; Liping Zhang; Ximei Liu; Li Li; Wenjun Hua; Hongwei Xiao; Jingrong Zhou; Qingxin Wei; Xinmin Zheng
Journal:  BMC Biotechnol       Date:  2012-07-06       Impact factor: 2.563

5.  Partial Deletion of Tie2 Affects Microvascular Endothelial Responses to Critical Illness in A Vascular Bed and Organ-Specific Way.

Authors:  Rianne M Jongman; Peter J Zwiers; Bart van de Sluis; Marleen van der Laan; Jill Moser; Jan G Zijlstra; Daphne Dekker; Nicolette Huijkman; Henk E Moorlag; Eliane R Popa; Grietje Molema; Matijs van Meurs
Journal:  Shock       Date:  2019-06       Impact factor: 3.454

6.  Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression.

Authors:  Robin M Ricke; Karthik B Jeganathan; Liviu Malureanu; Andrew M Harrison; Jan M van Deursen
Journal:  J Cell Biol       Date:  2012-12-03       Impact factor: 10.539

7.  Reduced life- and healthspan in mice carrying a mono-allelic BubR1 MVA mutation.

Authors:  Tobias Wijshake; Liviu A Malureanu; Darren J Baker; Karthik B Jeganathan; Bart van de Sluis; Jan M van Deursen
Journal:  PLoS Genet       Date:  2012-12-27       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.